These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30429288)

  • 21. Humanized Mouse Model as a Novel Approach in the Assessment of Human Allogeneic Responses in Organ Transplantation.
    Ajith A; Mulloy LL; Musa MA; Bravo-Egana V; Horuzsko DD; Gani I; Horuzsko A
    Front Immunol; 2021; 12():687715. PubMed ID: 34177940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of donor-specific microchimerism in liver transplant recipient with HLA-DRB1 and -DQB1 mismatch related to rejection episodes.
    Araújo MB; Leonardi LS; Boin IF; Leonardi MI; Magna LA; Donadi EA; Kraemer MH
    Transplant Proc; 2004 May; 36(4):953-5. PubMed ID: 15194331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The DQ barrier: improving organ allocation equity using HLA-DQ information.
    Tambur AR; Leventhal JR; Zitzner JR; Walsh RC; Friedewald JJ
    Transplantation; 2013 Feb; 95(4):635-40. PubMed ID: 23288109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza vaccination and humoral alloimmunity in solid organ transplant recipients.
    Vermeiren P; Aubert V; Sugamele R; Aubert JD; Venetz JP; Meylan P; Pascual M; Manuel O
    Transpl Int; 2014 Sep; 27(9):903-8. PubMed ID: 24797932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Qualitative, rather than quantitative, differences between HLA-DQ alleles affect HLA-DQ immunogenicity in organ transplantation.
    Maguire C; Crivello P; Fleischhauer K; Isaacson D; Casillas A; Kramer CSM; Copley HC; Heidt S; Kosmoliaptsis V; Meneghini M; Gmeiner M; Schold J; Louzoun Y; Tambur AR
    HLA; 2024 Apr; 103(4):e15455. PubMed ID: 38575370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A refractory case of subclinical antibody-mediated rejection due to anti-HLA-DQ antibody in a kidney transplant patient.
    Fujimoto T; Nakada Y; Yamamoto I; Kobayashi A; Tanno Y; Yamada H; Miki J; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():81-5. PubMed ID: 26031594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients.
    Kishikawa H; Kinoshita T; Hashimoto M; Fukae S; Taniguchi A; Yamanaka K; Nakagawa M; Nishimura K
    Transplant Proc; 2018 Oct; 50(8):2388-2391. PubMed ID: 30316363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human leukocyte antigen matching in organ transplantation: what we know and how can we make it better (Revisiting the past, improving the future).
    Tambur AR
    Curr Opin Organ Transplant; 2018 Aug; 23(4):470-476. PubMed ID: 29750676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of HLA-DQ Matching on Allograft Outcomes in Deceased Donor Kidney Transplantation.
    Khongjaroensakun N; Kitpoka P; Wiwattanathum P; Sakulchairungrueng B; Thammanichanond D
    Transplant Proc; 2018 Oct; 50(8):2371-2376. PubMed ID: 30316360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donor-specific antibodies present at the time of kidney transplantation in immunologically unmodified patients increase the risk of acute rejection.
    Gupta A; Murillo D; Yarlagadda SG; Wang CJ; Nawabi A; Schmitt T; Brimacombe M; Bryan CF
    Transpl Immunol; 2016 Jul; 37():18-22. PubMed ID: 27137749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
    Ntokou IS; Iniotaki AG; Kontou EN; Darema MN; Apostolaki MD; Kostakis AG; Boletis JN
    Transpl Int; 2011 Nov; 24(11):1084-93. PubMed ID: 21848902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-DQ antibodies in alloimmunity, what makes them different?
    Meneghini M; Tambur AR
    Curr Opin Organ Transplant; 2023 Oct; 28(5):333-339. PubMed ID: 37219535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-specific memory B-cell detection in kidney transplantation: Insights and future challenges.
    Wehmeier C; Karahan GE; Heidt S
    Int J Immunogenet; 2020 Jun; 47(3):227-234. PubMed ID: 32390325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donor-specific antibody to trans-encoded donor HLA-DQ heterodimer.
    Habig DF; Gaspari JL; Lokhandwala PM; Domen RE; Abendroth CS; Kadry Z; Ghahramani N; Shah RA; Jain A; Shike H
    Hum Immunol; 2015 Aug; 76(8):587-90. PubMed ID: 26382246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case report: binding of a clinically relevant human leukocyte antigen-DQα-specific antibody in a kidney graft recipient is inhibited by donor-type human leukocyte antigen-DQβ chain.
    Mikkelsen S; Korsholm T; Iburg A; Petersen MS; Møller BK
    Transplant Proc; 2013 Apr; 45(3):1209-12. PubMed ID: 23622661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA class II Eplet mismatch predicts De Novo DSA formation post lung transplant.
    Walton DC; Cantwell L; Hiho S; Ta J; Wright S; Sullivan LC; Snell GI; Westall GP
    Transpl Immunol; 2018 Dec; 51():73-75. PubMed ID: 30321645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy.
    Willicombe M; Brookes P; Sergeant R; Santos-Nunez E; Steggar C; Galliford J; McLean A; Cook TH; Cairns T; Roufosse C; Taube D
    Transplantation; 2012 Jul; 94(2):172-7. PubMed ID: 22735711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeated human leukocyte antigen mismatches in lung re-transplantation.
    Sommer W; Hallensleben M; Ius F; Kühn C; Tudorache I; Avsar M; Salman J; Siemeni T; Greer M; Gottlieb J; Boethig D; Blasczyk R; Haverich A; Warnecke G
    Transpl Immunol; 2017 Feb; 40():1-7. PubMed ID: 27923603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical significance of epitope mismatch load in kidney transplantation: A multicentre study.
    Daniëls L; Naesens M; Bosmans JL; Abramowicz D; Nagler E; Van Laecke S; Peeters P; Kuypers D; Emonds MP
    Transpl Immunol; 2018 Oct; 50():55-59. PubMed ID: 29908316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.
    Laging M; Kal-van Gestel JA; Haasnoot GW; Claas FH; van de Wetering J; Ijzermans JN; Weimar W; Roodnat JI
    Transplantation; 2014 Feb; 97(3):330-6. PubMed ID: 24202143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.